We are live on ! Find out more
FGP

Foyston, Gordon, & Payne Portfolio holdings

AUM $434M
1-Year Est. Return 9.09%
This Fund
S&P 500
This Quarter Est. Return
+1.89%
1 Year Est. Return
+9.09%
3 Year Est. Return
+56.86%
5 Year Est. Return
+84.63%
10 Year Est. Return
+238.52%
AUM
$421M
AUM Growth
-$97M
Cap. Flow
-$103M
Cap. Flow %
-24.48%
Top 10 Hldgs %
40.42%
Holding
78
New
4
Increased
9
Reduced
51
Closed
7

Top Buys

Rank Stock Value
1
AON icon
Aon
AON
+$11.4M
2
PEP icon
PepsiCo
PEP
+$6.17M
3
NVS icon
Novartis
NVS
+$6.03M
4
BTI icon
British American Tobacco
BTI
+$4.75M
5
NVO
Novo Nordisk
NVO
+$3.41M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$26.3M
2
MSFT icon
Microsoft
MSFT
+$6.91M
3
BG icon
Bunge Global
BG
+$5.72M
4
MDT icon
Medtronic
MDT
+$5.28M
5
UNP icon
Union Pacific
UNP
+$4.97M

Sector Composition

Rank Sector Weight
1 Healthcare 26.36%
2 Technology 15.78%
3 Industrials 13.89%
4 Financials 12.97%
5 Consumer Staples 9.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PPL
76
PPL Corp
PPL
$27.3B
– –
-70,949
Closed -$2.45M
SMFG icon
77
Sumitomo Mitsui Financial
SMFG
$163B
– –
-473,088
Closed -$3.19M
TEVA icon
78
Teva Pharmaceuticals
TEVA
$36.9B
– –
-572,656
Closed -$26.3M
1 2 3
4

Similar funds

HCM
Horiko Capital Management New York $434M AUM 47.96% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
IA
Icon Advisers Greenwood Village, Colorado $433M AUM 40.01% 1-Year Est. Return
PAMS
Pinpoint Asset Management (Singapore) Singapore $433M AUM 32.19% 1-Year Est. Return
SSWG
Seven Springs Wealth Group Brentwood, Tennessee $432M AUM 23% 1-Year Est. Return
JWM
JPL Wealth Management Highlands Ranch, Colorado $435M AUM 16.48% 1-Year Est. Return
GDS
Gimbel Daniel Scott $435M AUM 78.68% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Foyston, Gordon, & Payne's Q4 2016 Portfolio in Review

As of Q4 2016, Foyston, Gordon, & Payne held 78 positions worth $421M, down 19% from $518M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Foyston, Gordon, & Payne withdrew a net $103M in Q4 2016, closing 7 positions and reducing 51 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $26.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 32% a quarter earlier, followed by Technology and Industrials.

Against the trend, Foyston, Gordon, & Payne opened a new position in British American Tobacco worth $4.72M.

  • Foyston, Gordon, & Payne's largest Q4 2016 buy was British American Tobacco: 83,820 shares worth $4.72M.
  • Foyston, Gordon, & Payne added most to Aon in Q4 2016, an estimated $11.4M increase.
  • Foyston, Gordon, & Payne's biggest Q4 2016 reduction was Microsoft, cutting an estimated $6.91M.
  • Foyston, Gordon, & Payne fully exited Teva Pharmaceuticals in Q4 2016, selling an estimated $26.3M.
  • Foyston, Gordon, & Payne's ten largest holdings make up 40% of its $421M portfolio in Q4 2016.
  • Foyston, Gordon, & Payne opened 4 new positions and closed 7 in Q4 2016.
  • Foyston, Gordon, & Payne's portfolio value fell 19% quarter-over-quarter to $421M.

Based on Foyston, Gordon, & Payne's 13F filing for Q4 2016, filed 13 Feb 2017.